{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/angio-oedema-anaphylaxis/management/anaphylaxis-with-or-without-angio-oedema/","result":{"pageContext":{"chapter":{"id":"5759117d-4bde-53b6-b78d-7885ccbf431e","slug":"anaphylaxis-with-or-without-angio-oedema","fullItemName":"Scenario: Anaphylaxis with or without angio-oedema","depth":2,"htmlHeader":"<!-- begin field 80858755-ab8b-4458-98dd-33b1469faa8a --><h2>Scenario: Anaphylaxis with or without angio-oedema</h2><!-- end field 80858755-ab8b-4458-98dd-33b1469faa8a -->","summary":"Covers the management and follow up of a person with suspected anaphylaxis.","htmlStringContent":"<!-- begin item 0b541676-248c-4de4-82f6-91c44e178a96 --><!-- begin field 6e31acab-43be-4b97-a48d-acbc0155b60f --><p>From birth onwards.</p><!-- end field 6e31acab-43be-4b97-a48d-acbc0155b60f --><!-- end item 0b541676-248c-4de4-82f6-91c44e178a96 -->","topic":{"id":"4e83ca20-0eac-5432-adf1-cb9a0716c558","topicId":"41b219ac-b62a-42d3-9d76-7b3897b21bdd","topicName":"Angio-oedema and anaphylaxis","slug":"angio-oedema-anaphylaxis","lastRevised":"Last revised in November 2018","chapters":[{"id":"f7de7576-f193-57e1-8566-52f77c198d07","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"137d41e2-195c-5b6c-a42b-a2e7774ab4c5","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2d19b26a-ca5e-5feb-8be8-12f596f24eed","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"76defb8d-d620-56bc-bf42-cc72dd02704f","slug":"changes","fullItemName":"Changes"},{"id":"0124664c-1848-504a-b629-b001f3d627e7","slug":"update","fullItemName":"Update"}]},{"id":"fd3fe5d3-198d-5e2e-afaa-1de509ee14b0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8c36d3c5-8fc2-58ba-91d9-2d00dbb17605","slug":"goals","fullItemName":"Goals"},{"id":"dbfbfeb0-8ad4-5a3d-8458-06af672eab12","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bbc732dc-6fbc-5902-a5bf-890776f1df44","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"49ccfcd1-6054-5eac-b6a2-c85eb605ecfd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4c97855a-e489-54e6-8f4b-28dbc050951e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"71eafab9-7c66-5e57-aa08-197ad09eb9e7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2c158e9f-bfe1-56ea-a1fe-97e4da83b82d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ed1b7bb1-0232-5ceb-991c-c936ac2a3086","slug":"definition","fullItemName":"Definition"},{"id":"ac67665b-2b88-5df8-9a70-cc35f96825ae","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"a4358430-db1f-55c2-9d68-6ce8076813ba","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7ebee135-258e-58ce-a91e-947b8a2f9563","slug":"complications","fullItemName":"Complications"},{"id":"7c2a6ca1-0f6a-5a40-bc06-dbbbf95c57c1","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4b20303c-5905-594a-a8c6-4f85e46cf3f9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"005b06b8-18c4-569f-b1b3-3c6d1218ddf7","slug":"diagnosis-of-angio-oedema","fullItemName":"Diagnosis of angio-oedema"},{"id":"682e56cf-4c4d-5736-8db7-4cd4bfcab6e2","slug":"assessing-the-cause-of-angio-oedema","fullItemName":"Assessing the cause of angio-oedema"},{"id":"bf860a63-b9a4-5c14-bf1b-46423d3df7ad","slug":"diagnosis-of-anaphylaxis","fullItemName":"Diagnosis of anaphylaxis"},{"id":"fab5c932-e15e-5303-99e9-48f7d2e415b4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1c5f38ef-17d4-569d-ad54-b819fd953d6c","fullItemName":"Management","slug":"management","subChapters":[{"id":"654a5e70-49b7-58b4-b976-7e94c44b3074","slug":"angio-oedema-without-anaphylaxis","fullItemName":"Scenario: Angio-oedema without anaphylaxis"},{"id":"5759117d-4bde-53b6-b78d-7885ccbf431e","slug":"anaphylaxis-with-or-without-angio-oedema","fullItemName":"Scenario: Anaphylaxis with or without angio-oedema"}]},{"id":"6f94e28f-193d-587a-a11a-0a05a1be037f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b59ab8fd-de1f-555e-946a-c3a53b918da4","slug":"emergency-drug-doses","fullItemName":"Emergency drug doses"},{"id":"69e007b8-2046-5946-a7b5-de8f1bb9de9f","slug":"non-sedating-antihistamines-no-airway-involvement","fullItemName":"Non-sedating antihistamines (no airway involvement)"},{"id":"dac089ca-3b63-536d-9737-82806f78b88e","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"7ead2f48-36a4-5547-8570-4d4ab5898a73","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a7653e34-460d-5737-b0c3-264ecc26dc68","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a713ee82-3188-50ea-a2bc-a562abd97621","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7421fd02-2e34-5526-bd39-905aa772f800","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d24df800-eddc-5bf3-bea0-d556b5e01aed","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"af27ed5c-0853-5d16-91a4-5e5878ee9209","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f7640a76-8bc4-569e-8b82-717e6bd5f041","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b4778aa1-f37d-574f-8514-47ac86bf2c2e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"1c5f38ef-17d4-569d-ad54-b819fd953d6c","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"bf74b2c1-9251-5555-9cf9-a2efecf58b7b","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 0a970eaa-4dd1-4bb1-acd0-eb35849f70c5 --><h3>How should I manage a person with anaphylaxis with or without angio-oedema?</h3><!-- end field 0a970eaa-4dd1-4bb1-acd0-eb35849f70c5 -->","summary":null,"htmlStringContent":"<!-- begin item d0745091-e92b-4201-856c-295dd44798e1 --><!-- begin field 71a491e5-667c-4cef-a6a7-bcc69592f26d --><p><strong>The Working Group of the Resuscitation Council (UK) advises that the Airway, Breathing, Circulation, Disability, and Exposure (ABCDE) approach (summarized below) is used to <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/diagnosis/diagnosis-of-anaphylaxis/\">recognize</a> and manage people with suspected anaphylaxis. For detailed information on this approach, see Appendix 1 of the <a href=\"https://www.resus.org.uk/anaphylaxis/emergency-treatment-of-anaphylactic-reactions/\" data-hyperlink-id=\"bfc73b58-1a86-4964-b280-a99200d4bde5\">Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers</a> available on the Resuscitation Council (UK) website (<a href=\"https://www.resus.org.uk/\" data-hyperlink-id=\"0e452492-9ad0-47bb-9cbd-a99200d4be42\">www.resus.org.uk</a>).</strong></p><p><strong>If a person presents </strong><strong><strong>with </strong><a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/diagnosis/diagnosis-of-anaphylaxis/\">features of anaphylaxis</a></strong><strong> with or without angio-oedema:</strong></p><ul><li><strong>Treat as a medical emergency.</strong> Call for an ambulance and ask for help from colleagues.</li><li><strong>Assess the person.</strong><ul><li>Look for and relieve airway obstruction.</li><li>Check for normal breathing.</li><li><strong>If the person is unresponsive and not breathing normally:</strong><ul><li>Start cardiopulmonary resuscitation (CPR) immediately. </li><li>Ensure that help is on its way as early advanced life support is essential. </li></ul></li><li><strong>For people who do not require CPR:</strong><ul><li>Examine the chest for signs of lower and upper airway obstruction.</li><li>Check the pulse and blood pressure for signs of circulatory collapse.</li><li>Check the skin and inside the mouth for urticaria and angio-oedema.</li></ul></li></ul></li><li><strong>Place the person in a comfortable position.</strong><ul><li>People with airway and breathing problems may prefer to sit up as this will make breathing easier.</li><li>Lying flat with or without leg elevation is helpful for people with low blood pressure. If the person feels faint, do not sit or stand them up as this can cause cardiac arrest.</li><li>Place people who are breathing and unconscious on their side (recovery position).</li><li>Pregnant women should lie on their left side to prevent caval compression.</li></ul></li><li><strong>Give intramuscular (IM) adrenaline 1:1000 as per <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/prescribing-information/emergency-drug-doses/\">age-related guidelines</a>.</strong><ul><li>The injection can be given in the anterolateral aspect of the middle third of the thigh (ideally) or arm, depending on access.</li><li>Assess the response to treatment after 5 minutes, and repeat IM adrenaline at 5 minute intervals until there has been an adequate response.</li><li><strong>Do not give intravenous (IV) adrenaline in primary care.</strong></li></ul></li><li><strong>Remove the trigger if possible.</strong><ul><li>For example, remove the stinger after a bee sting. Early removal is more important than the method of removal.</li><li>After food-induced anaphylaxis, attempts to make the person vomit are not recommended.</li><li>Do not delay definitive treatment if removing the trigger is not feasible.</li></ul></li><li><strong>Where skills and equipment are available:</strong><ul><li>Give oxygen at the highest concentration possible.</li><li>Obtain IV access and give a rapid fluid challenge (with Hartmann's or normal saline) using 500–1000 mls in an adult or 20 mL/kg in a child.</li><li>Monitor the ECG and pulse oximetry continuously, and the blood pressure and pulse every 5 minutes.</li></ul></li><li><strong>Following initial resuscitation:</strong><ul><li>Give slow IM or IV <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/prescribing-information/emergency-drug-doses/\">chlorphenamine</a>.</li><li>Give slow IM or IV <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/prescribing-information/emergency-drug-doses/\">hydrocortisone</a> (especially in people with asthma).</li><li>Consider nebulized salbutamol or ipratropium if the person is wheezy (especially in people with known asthma).</li></ul></li><li><strong>Arrange a review after the person has been discharged from hospital. </strong>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/management/anaphylaxis-with-or-without-angio-oedema/#follow-up\">Follow up</a> for more information.</li></ul><!-- end field 71a491e5-667c-4cef-a6a7-bcc69592f26d --><!-- end item d0745091-e92b-4201-856c-295dd44798e1 -->","subChapters":[{"id":"66480634-5b1f-5f28-b2aa-9c5648cda130","slug":"basis-for-recommendation-6a1","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 1f8edb62-e31f-44db-8280-caae2ab00fff --><h4>Basis for recommendation</h4><!-- end field 1f8edb62-e31f-44db-8280-caae2ab00fff -->","summary":null,"htmlStringContent":"<!-- begin item 6a15e959-0993-4972-b8dd-3eecf24e8245 --><!-- begin field 49291623-98e7-496b-b3c7-7d07d9fdc202 --><p>These recommendations are largely based on the <em>Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers </em>published by the<em> </em>Working Group of the Resuscitation Council (UK)<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Resuscitation Council (UK), 2012</a>] and are in line with recommendations in several national and international guidelines, including the <em>Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Muraro, 2014</a>].</p><h5>Treating as a medical emergency</h5><ul><li>Anaphylaxis causes around 20 deaths each year in the UK, although this may be an underestimate. Approximately 50% of fatalities are due to circulatory collapse (shock) and the rest are due to respiratory failure (asphyxia) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Resuscitation Council (UK), 2012</a>]. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/background-information/complications/\">Complications</a> for more information.</li></ul><h5>Adrenaline</h5><ul><li>Adrenaline is the most important drug for the treatment of an anaphylactic reaction and should be given as early as possible to alleviate symptoms.<ul><li>Although there are no randomized controlled trials, there is consistent anecdotal evidence supporting its use to ease breathing difficulty and restore adequate cardiac output.</li><li>Adrenaline is a direct-acting sympathomimetic drug that acts as an agonist at alpha and beta-adrenergic receptors.<ul><li>It acts on alpha-receptors to reverse peripheral vasodilation and reduce oedema.</li><li>It acts on beta-receptors to dilate the bronchial airways, increases the force of myocardial contraction, and suppresses histamine and leukotriene release.</li><li>There are also beta-2 adrenergic receptors on mast cells that inhibit activation; early treatment with adrenaline attenuates the severity of immunoglobulin E (IgE)-mediated allergic reactions. </li></ul></li><li>There are no absolute contraindications to adrenaline in a severe allergic reaction involving the airway or circulatory collapse. </li></ul></li><li>The intramuscular route is recommended for most healthcare professionals because there is a greater margin of safety and it is easier to administer the treatment via this route. As an injection site, the thigh has a quicker rate of absorption compared with the arm.<ul><li>Intravenous (IV) adrenaline should only be given by experienced specialists (such as anaesthetists and emergency department physicians) because of the greater risk of causing harmful adverse effects by inappropriate dosing. </li></ul></li><li>Previous guidelines recommended halving the adrenaline dose in certain circumstances, for example in people taking tricyclic antidepressants (which inhibit reuptake of directly acting sympathomimetic agents and may theoretically potentiate the effect of adrenaline).<ul><li>The Working Group of the Resuscitation Council (UK) considered it unhelpful to have this caveat in the setting of an acute anaphylactic reaction [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Resuscitation Council (UK), 2012</a>].</li><li>Expert opinion in the British Society for Allergy and Clinical Immunology (BSACI) guideline <em>BSACI guideline: prescribing an adrenaline auto-injector </em>is that people taking these drugs should not be denied adrenaline in anaphylaxis, but adrenaline use should be restricted to severe reactions and there should be caution with dose [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Ewan, 2016</a>]. </li></ul></li></ul><h5>Antihistamines</h5><ul><li>H1-antihistamines are a second-line treatment for an anaphylactic reaction.</li><li>The evidence to support their use is weak, but it is thought that they may help counter histamine-mediated vasodilation and bronchoconstriction.</li><li>They may not help in reactions depending in part on other mediators, but they are safe to use.</li><li>If used alone, antihistamines are unlikely to be lifesaving in a true anaphylactic reaction. </li></ul><h5>Corticosteroids (given after initial resuscitation)</h5><ul><li>Corticosteroids may help prevent or shorten protracted anaphylactic reactions. They are also thought to play a role in preventing <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/diagnosis/diagnosis-of-anaphylaxis/\">biphasic reactions</a>, but the evidence for this is lacking.</li><li>They have a delayed response and are unlikely to be helpful in the treatment of acute anaphylaxis. They should not be used in isolation for anaphylaxis.</li><li>Corticosteroids may also provide additional benefit for people with associated asthma. </li></ul><h5>Bronchodilators</h5><ul><li>The presenting symptoms and signs of a severe anaphylactic reaction and life-threatening asthma can be the same.</li><li>Resuscitation Council (UK) advises that [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Resuscitation Council (UK), 2012</a>]:<ul><li>In addition to the recommended treatments, further bronchodilator therapy with salbutamol (inhaled or IV), ipratropium (inhaled), aminophylline (IV), or magnesium (IV) may be considered.</li><li>If the person has asthma-like features alone, the joint British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) <a href=\"https://www.brit-thoracic.org.uk/standards-of-care/guidelines/btssign-british-guideline-on-the-management-of-asthma/\" data-hyperlink-id=\"5185fc19-bfac-4adc-ac16-a98e00ced756\">Asthma Guidelines</a> should be followed. </li></ul></li></ul><!-- end field 49291623-98e7-496b-b3c7-7d07d9fdc202 --><!-- end item 6a15e959-0993-4972-b8dd-3eecf24e8245 -->","subChapters":[]}]},{"id":"b6a19ba7-9aae-59c6-b1ff-9dace0746297","slug":"follow-up","fullItemName":"Follow up","depth":3,"htmlHeader":"<!-- begin field b1d3f408-b9c9-434c-b8f5-d036f8f163b2 --><h3>How should I follow up a person after treatment for anaphylaxis?</h3><!-- end field b1d3f408-b9c9-434c-b8f5-d036f8f163b2 -->","summary":null,"htmlStringContent":"<!-- begin item e5c8e662-9db7-4c78-9343-4f1d453178ba --><!-- begin field 6d92151d-a8a9-4b6e-b09c-934418c2012e --><p><strong>Following emergency treatment for suspected anaphylaxis: </strong></p><ul><li><strong>Ensure that the person has been offered:</strong><ul><li>Referral to a specialist allergy service<strong> </strong>(age-appropriate where possible) consisting of healthcare professionals with the skills and competencies necessary to accurately investigate, diagnose, monitor, and provide ongoing management of, and patient education on, suspected anaphylaxis.</li><li>An appropriate adrenaline auto-injector as an interim measure before their specialist allergy service appointment.<ul><li>Two adrenaline auto-injectors should be provided.  </li><li>The person should be given a demonstration of the correct use of the adrenaline auto-injector and advice on when to use it.</li></ul></li></ul></li><li><strong>Ensure the person has been given information on anaphylaxis, including:</strong><ul><li>Information on:<ul><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/diagnosis/diagnosis-of-anaphylaxis/\">symptoms and signs of anaphylaxis</a>.</li><li>The risk of a <a class=\"topic-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/diagnosis/diagnosis-of-anaphylaxis/\">biphasic reaction</a>.</li></ul></li><li>Advice to:<ul><li>Carry two adrenaline auto-injectors at all times and to check the expiry dates and obtain replacements before they expire. Expired injectors will be less effective.</li><li>Consider wearing some device, such as a bracelet (for example <a data-hyperlink-id=\"ac28b050-e5f0-4685-9b10-a98f00232d84\" href=\"https://www.medicalert.org.uk/\">Medic Alert</a>), that provides information on their history of anaphylactic reaction.</li></ul></li><li>Information on what to do if an anaphylactic reaction occurs. They should:<ul><li>Use one adrenaline auto-injector and then call 999, ask for an ambulance, and state 'anaphylaxis', even if symptoms are improving.</li><li>Lie flat with the legs raised in order to maintain blood flow. If the person has breathing difficulties, they should sit up to make breathing easier.</li><li>Use the second auto-injector if they don't start to feel better 5 to 15 minutes after the first injection. </li></ul></li><li>Advice on:<ul><li>How to avoid the suspected trigger (if known).</li><li>The importance of the referral to a specialist allergy service.</li></ul></li><li>Information leaflets on anaphylaxis.<ul><li>NHS A-Z has printable information on <a data-hyperlink-id=\"2e799d62-74d9-4d64-a5a8-a98f00232db0\" href=\"https://www.nhs.uk/conditions/anaphylaxis/\">Anaphylaxis</a>.</li><li>Anaphylaxis Campaign has factsheets on <a data-hyperlink-id=\"15dd1101-de77-4568-8167-a98f00232e26\" href=\"https://www.anaphylaxis.org.uk/wp-content/uploads/2015/06/Anaphylaxis-2015-version-8-with-links-in-full-1.pdf\">Anaphylaxis</a> and <a data-hyperlink-id=\"da4412ff-4b36-4b34-b13a-a98f00232e54\" href=\"https://www.anaphylaxis.org.uk/wp-content/uploads/2015/06/Adrenaline-version-9-with-2nd-call-to-999-EMA-link-in-full.pdf\">Adrenaline</a>.</li><li>Allergy UK, a national charity dedicated to supporting allergy sufferers in the UK, has a factsheet on <a data-hyperlink-id=\"a8f03cdd-65e5-47d2-8aed-a98f00232ed4\" href=\"https://www.allergyuk.org/information-and-advice/conditions-and-symptoms/33-anaphylaxis-and-severe-allergic-reaction\">Anaphylaxis and Severe Allergic Reaction</a>. It also has a dedicated <a data-hyperlink-id=\"7a0df6b2-3b2e-4a2d-af2e-a98f00232f21\" href=\"http://www.allergyuk.org/getting-help/allergy-uk-helpline\">helpline</a> and an <a data-hyperlink-id=\"1b47518b-957f-41e0-a109-a98f00232f53\" href=\"http://forum.allergyuk.org/\">online forum</a> for people with allergies. </li><li>The Medicines and Healthcare products Regulatory Agency (MHRA) has published information on <a data-hyperlink-id=\"54a1ba3d-c207-4175-93c0-a98f00232f61\" href=\"http://assets.publishing.service.gov.uk/media/54730805ed915d1380000045/con418524.pdf\">Adrenaline auto-injectors</a> for people with allergies and their carers.</li></ul></li></ul></li></ul><!-- end field 6d92151d-a8a9-4b6e-b09c-934418c2012e --><!-- end item e5c8e662-9db7-4c78-9343-4f1d453178ba -->","subChapters":[{"id":"1eae1f18-b6c4-5928-9c30-dffde7aa9cff","slug":"basis-for-recommendation-475","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 66bd3cc7-d3e7-43df-ad0e-06135f80c9e9 --><h4>Basis for recommendation</h4><!-- end field 66bd3cc7-d3e7-43df-ad0e-06135f80c9e9 -->","summary":null,"htmlStringContent":"<!-- begin item 475dbb58-40f0-441a-aeb2-c1c02a279bb0 --><!-- begin field 01fcdcf3-9f86-4c46-8253-7b5c47b322dd --><p>These recommendations are based on the guidelines <em>Anaphylaxis: assessment to confirm an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode </em>published by the<em> </em>National Institute for Health and Care Excellence (NICE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">National Clinical Guideline Centre, 2011</a>], <em>Adrenaline auto-injector advice for patients </em>published by the the Medicines and Healthcare Products Regulatory Agency (MHRA) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">MHRA, 2014</a>], the <em>Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers </em>published by the Working Group of the Resuscitation Council (UK)<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Resuscitation Council (UK), 2012</a>], and the <em>BSACI guideline: prescribing an adrenaline auto-injector </em>published by the British Society for Allergy and Clinical Immunology (BSACI) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/angio-oedema-anaphylaxis/references/\">Ewan, 2016</a>].</p><!-- end field 01fcdcf3-9f86-4c46-8253-7b5c47b322dd --><!-- end item 475dbb58-40f0-441a-aeb2-c1c02a279bb0 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}